For: | Ungrungseesopon N, Wongtanasarasin W. Pain reduction and adverse effects of intravenous metoclopramide for acute migraine attack: A systematic review and meta-analysis of randomized-controlled trials. World J Methodol 2022; 12(4): 319-330 [PMID: 36159095 DOI: 10.5662/wjm.v12.i4.319] |
---|---|
URL: | https://www.wjgnet.com/2222-0682/full/v12/i4/319.htm |
Number | Citing Articles |
1 |
Hanaa Abdelmonem, Hebatallah Mohamed Abdelhay, Gehad Taha Abdelwadoud, Amira Naser Mohammed Alhosini, Ahmed Eissa Ahmed, Samaher Walied Mohamed, Nada Mostafa Al-dardery, Mohamed Abd-ElGawad, Mohamed Abdelmonem Kamel. The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials. BMC Neurology 2023; 23(1) doi: 10.1186/s12883-023-03259-7
|
2 |
Rakesh Kumar Singh, Shivam Kumar Pandey, Shreya Singh, Apoorva Chittoda, Sakshi Arun Chaudhari. Management of Migraine Pain. 2024; : 191 doi: 10.1007/978-981-97-4529-6_11
|